Altimmune Stock Price History
| ALT Stock | USD 7.00 0.05 0.72% |
Below is the normalized historical share price chart for Altimmune extending back to October 06, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Altimmune stands at 7.00, as last reported on the 31st of January, with the highest price reaching 7.14 and the lowest price hitting 6.90 during the day.
If you're considering investing in Altimmune Stock, it is important to understand the factors that can impact its price. Altimmune appears to be slightly risky, given 3 months investment horizon. Altimmune secures Sharpe Ratio (or Efficiency) of 0.0361, which signifies that the company had a 0.0361 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Altimmune, which you can use to evaluate the volatility of the firm. Please makes use of Altimmune's Risk Adjusted Performance of 0.0382, mean deviation of 3.8, and Downside Deviation of 4.94 to double-check if our risk estimates are consistent with your expectations.
At this time, Altimmune's Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 64.3 M in 2025, whereas Capital Stock is likely to drop 4,065 in 2025. . At this time, Altimmune's Price To Sales Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 2.92 in 2025, despite the fact that Price To Free Cash Flows Ratio is likely to grow to (8.63). Altimmune Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of October 2005 | 200 Day MA 7.161 | 50 Day MA 7.8642 | Beta 0.072 |
Altimmune |
Sharpe Ratio = 0.0361
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.9 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Altimmune is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Altimmune by adding it to a well-diversified portfolio.
Price Book 3.7328 | Enterprise Value Ebitda (4.20) | Price Sales 9.6 K | Shares Float 70.6 M | Wall Street Target Price 22.25 |
Altimmune Stock Price History Chart
There are several ways to analyze Altimmune Stock price data. The simplest method is using a basic Altimmune candlestick price chart, which shows Altimmune price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 4, 2024 | 9.85 |
| Lowest Price | January 14, 2025 | 6.23 |
Altimmune January 31, 2025 Stock Price Synopsis
Various analyses of Altimmune's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Altimmune Stock. It can be used to describe the percentage change in the price of Altimmune from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Altimmune Stock.| Altimmune Price Rate Of Daily Change | 1.01 | |
| Altimmune Accumulation Distribution | 52,951 | |
| Altimmune Price Daily Balance Of Power | 0.21 |
Altimmune January 31, 2025 Stock Price Analysis
Altimmune Stock Price History Data
The price series of Altimmune for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 has a statistical range of 3.62 with a coefficient of variation of 11.82. The prices are distributed with arithmetic mean of 7.74. The median price for the last 90 days is 7.46. The company had 1:30 stock split on 14th of September 2018. Altimmune issued dividends on 2017-01-20.| Open | High | Low | Close | Volume | ||
| 01/30/2025 | 7.00 | 7.14 | 6.90 | 7.00 | 1,575,283 | |
| 01/29/2025 | 6.90 | 7.18 | 6.85 | 6.95 | 2,924,245 | |
| 01/28/2025 | 7.00 | 7.05 | 6.83 | 6.93 | 1,469,305 | |
| 01/27/2025 | 6.85 | 7.12 | 6.77 | 7.00 | 2,144,407 | |
| 01/24/2025 | 7.12 | 7.42 | 6.90 | 6.98 | 2,355,252 | |
| 01/23/2025 | 6.86 | 7.16 | 6.72 | 7.06 | 1,565,684 | |
| 01/22/2025 | 6.81 | 7.01 | 6.78 | 6.94 | 1,714,572 | |
| 01/21/2025 | 6.96 | 7.01 | 6.73 | 6.83 | 1,321,463 | |
| 01/17/2025 | 6.80 | 6.99 | 6.73 | 6.86 | 1,687,895 | |
| 01/16/2025 | 6.63 | 6.83 | 6.46 | 6.71 | 1,606,106 | |
| 01/15/2025 | 6.50 | 6.67 | 6.41 | 6.58 | 2,206,153 | |
| 01/14/2025 | 6.78 | 6.82 | 6.19 | 6.23 | 3,740,032 | |
| 01/13/2025 | 6.67 | 6.82 | 6.58 | 6.78 | 1,854,824 | |
| 01/10/2025 | 7.23 | 7.26 | 6.70 | 6.87 | 3,895,437 | |
| 01/08/2025 | 7.54 | 7.83 | 7.30 | 7.45 | 2,744,164 | |
| 01/07/2025 | 7.25 | 7.52 | 7.13 | 7.31 | 2,216,171 | |
| 01/06/2025 | 7.36 | 7.57 | 7.22 | 7.25 | 2,792,618 | |
| 01/03/2025 | 7.18 | 7.38 | 7.13 | 7.26 | 2,728,610 | |
| 01/02/2025 | 7.31 | 7.41 | 6.95 | 7.11 | 2,405,690 | |
| 12/31/2024 | 7.40 | 7.53 | 7.05 | 7.21 | 2,652,625 | |
| 12/30/2024 | 7.46 | 7.61 | 7.17 | 7.32 | 2,101,703 | |
| 12/27/2024 | 7.90 | 8.03 | 7.48 | 7.67 | 1,913,858 | |
| 12/26/2024 | 7.47 | 8.05 | 7.37 | 8.00 | 2,184,508 | |
| 12/24/2024 | 7.76 | 7.80 | 7.50 | 7.55 | 1,339,650 | |
| 12/23/2024 | 8.22 | 8.25 | 7.69 | 7.76 | 2,884,064 | |
| 12/20/2024 | 8.31 | 8.75 | 8.18 | 8.25 | 4,889,930 | |
| 12/19/2024 | 8.10 | 8.47 | 7.87 | 8.18 | 2,844,370 | |
| 12/18/2024 | 8.38 | 8.58 | 7.70 | 7.90 | 4,739,864 | |
| 12/17/2024 | 8.85 | 8.88 | 8.32 | 8.40 | 2,835,258 | |
| 12/16/2024 | 9.06 | 9.59 | 8.95 | 9.00 | 2,674,703 | |
| 12/13/2024 | 8.64 | 9.16 | 8.46 | 9.03 | 3,010,695 | |
| 12/12/2024 | 8.83 | 9.10 | 8.48 | 8.59 | 2,505,032 | |
| 12/11/2024 | 9.05 | 9.15 | 8.65 | 8.74 | 3,212,944 | |
| 12/10/2024 | 9.59 | 9.95 | 8.95 | 9.01 | 2,810,797 | |
| 12/09/2024 | 9.14 | 9.79 | 9.01 | 9.64 | 2,767,242 | |
| 12/06/2024 | 9.16 | 9.90 | 9.04 | 9.11 | 3,323,188 | |
| 12/05/2024 | 10.02 | 10.11 | 9.07 | 9.14 | 4,676,741 | |
| 12/04/2024 | 9.41 | 10.88 | 9.19 | 9.85 | 10,976,374 | |
| 12/03/2024 | 8.77 | 9.49 | 8.64 | 8.79 | 4,374,847 | |
| 12/02/2024 | 8.59 | 8.87 | 8.57 | 8.85 | 1,720,045 | |
| 11/29/2024 | 8.79 | 8.87 | 8.48 | 8.57 | 1,145,004 | |
| 11/27/2024 | 8.43 | 9.00 | 8.23 | 8.73 | 2,236,057 | |
| 11/26/2024 | 8.68 | 9.23 | 8.39 | 8.43 | 2,139,164 | |
| 11/25/2024 | 8.93 | 9.19 | 8.52 | 8.57 | 2,189,294 | |
| 11/22/2024 | 8.42 | 8.84 | 8.28 | 8.68 | 2,235,718 | |
| 11/21/2024 | 8.06 | 9.06 | 7.91 | 8.40 | 4,396,869 | |
| 11/20/2024 | 7.61 | 8.42 | 7.52 | 8.05 | 4,748,042 | |
| 11/19/2024 | 7.04 | 7.48 | 6.98 | 7.47 | 2,787,014 | |
| 11/18/2024 | 7.55 | 7.59 | 6.95 | 7.15 | 4,476,307 | |
| 11/15/2024 | 8.27 | 8.54 | 7.46 | 7.61 | 5,396,465 | |
| 11/14/2024 | 9.55 | 9.70 | 8.33 | 8.46 | 5,190,169 | |
| 11/13/2024 | 9.75 | 11.16 | 9.46 | 9.52 | 10,075,121 | |
| 11/12/2024 | 7.62 | 10.02 | 7.46 | 9.49 | 18,676,401 | |
| 11/11/2024 | 7.89 | 7.96 | 6.92 | 7.35 | 4,784,643 | |
| 11/08/2024 | 7.45 | 7.68 | 7.37 | 7.68 | 1,938,403 | |
| 11/07/2024 | 7.75 | 8.05 | 7.40 | 7.46 | 4,229,561 | |
| 11/06/2024 | 7.26 | 7.41 | 7.08 | 7.31 | 2,676,676 | |
| 11/05/2024 | 6.76 | 7.03 | 6.64 | 7.03 | 1,678,684 | |
| 11/04/2024 | 6.69 | 6.84 | 6.45 | 6.79 | 2,062,915 | |
| 11/01/2024 | 6.82 | 7.20 | 6.62 | 6.74 | 2,126,301 | |
| 10/31/2024 | 6.74 | 6.86 | 6.58 | 6.74 | 1,666,310 |
About Altimmune Stock history
Altimmune investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Altimmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Altimmune will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Altimmune stock prices may prove useful in developing a viable investing in Altimmune
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 61.2 M | 64.3 M | |
| Net Loss | -76.2 M | -72.4 M |
Altimmune Quarterly Net Working Capital |
|
Altimmune Stock Technical Analysis
Altimmune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Altimmune Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Altimmune's price direction in advance. Along with the technical and fundamental analysis of Altimmune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Altimmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0382 | |||
| Jensen Alpha | 0.0018 | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | 0.021 | |||
| Treynor Ratio | 0.0907 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.